Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study

被引:35
|
作者
Gold, Michael S. [1 ]
Gidudu, Jane [2 ]
Erlewyn-Lajeunesse, Mich [3 ]
Law, Barbara [4 ]
机构
[1] Univ Adelaide, Discipline Paediat, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia
[2] Ctr Dis Control & Prevent, Atlanta, GA USA
[3] Southampton Univ Hosp NHS Trust, Southampton, Hants, England
[4] Publ Hlth Agcy Canada, Sci Sect, Immunizat & Resp Infect Div, Ottawa, ON, Canada
关键词
Brighton Collaboration anaphylaxis case definition; Checklists; Immunization safety; Case study; SAFETY DATA; GUIDELINES; COLLECTION;
D O I
10.1016/j.vaccine.2010.04.041
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Brighton Collaboration (BC) was established in 2000 with the aim of developing globally accepted standardized case definitions for adverse events following immunizations (AEFI) as well as guidelines for the collection, analysis and presentation of surveillance data. Some of the BC case definitions are complex and this may limit their application for use in post-marketing vaccine surveillance. Barriers to the application of the BC case definitions include an incomplete description of an adverse event and inconsistencies in reporter use of adverse event terms. We have taken the BC case definition for anaphylaxis and developed a clinical checklist and glossary of terms used in the case definition. It is anticipated that these resources can be used at a community level by AEFI reporters. If used, these resources could improve the quality of adverse event reports which would facilitate the application of the BC case definition at a regional and/or national level. (C) 2010 Published by Elsevier Ltd.
引用
收藏
页码:4487 / 4498
页数:12
相关论文
共 50 条
  • [11] Health Workers' Knowledge, Attitudes, and Practices on Reporting Adverse Events Following Immunization (AEFI) in Nigeria: A Cross-sectional Study
    Olaoye, Itse
    Fatiregun, Akinola A.
    Myrissa, Kyriaki
    Kelaiditi, Eirini
    Ekong, Aniebet
    Jacdonmi, Tsemaye
    Gboyega, Famokun
    Stephen, Fagbemi
    JOURNAL OF HEALTH RESEARCH, 2023, 37 (04) : 224 - 234
  • [12] Understanding and experience of adverse event following immunization (AEFI) and its consequences among healthcare providers in Kebbi State, Nigeria: a qualitative study
    Semeeh Akinwale Omoleke
    Biniam Getachew
    Abubakar Isyaku
    Abdulrasheed Bello Aliyu
    Ashiru Mohammed Mustapha
    Shafiu Muhammad Dansanda
    Kehinde Kazeem Kanmodi
    Hafsat Abubakar
    Zahraddeen Ibrahim Lawal
    Haruna Abdullahi Kangiwa
    BMC Health Services Research, 22
  • [13] A Randomized, Single Centered, Parallel and Open Labelled Interventional Study on Effectiveness of Clinical Pharmacists on Adverse Event Following Immunization (AEFI) in Pediatric Population
    Arvind, Ronit K.
    Beerwala, Faizan A.
    Wali, Shashikala C.
    Parihar, Ashish S.
    Ganachari, Madiwalayya S.
    Bhandari, Ramesh
    CURRENT DRUG SAFETY, 2022, 17 (04) : 357 - 365
  • [14] Analysis of individual case safety reports of drug-induced anaphylaxis to the Korea Adverse Event Reporting System
    Cho, Min Kyoung
    Moon, Mira
    Kim, Hyun Hwa
    Kang, Dong Yoon
    Lee, Ju-Yeun
    Cho, Sang-Heon
    Kang, Hye-Ryun
    ALLERGY ASTHMA & RESPIRATORY DISEASE, 2020, 8 (01): : 30 - 35
  • [15] Development of case definitions for acute encephalopathy, encephalitis, and multiple sclerosis reports to the Vaccine Adverse Event Reporting System
    Ball, R
    Halsey, N
    Braun, NM
    Moulton, LH
    Gale, AD
    Rammohan, K
    Wiznitzer, M
    Johnson, R
    Salive, ME
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2002, 55 (08) : 819 - 824
  • [16] Narcolepsy as an adverse event following immunization: Case definition and guidelines for data collection, analysis and presentation
    Poli, Francesca
    Overeem, Sebastiaan
    Lammers, Gert Jan
    Plazzi, Giuseppe
    Lecendreux, Michel
    Bassetti, Claudio L.
    Dauvilliers, Yves
    Keene, Daniel
    Khatami, Ramin
    Li, Yulin
    Mayer, Geert
    Nohynek, Hanna
    Pahud, Barbara
    Paiva, Teresa
    Partinen, Markku
    Scammell, Thomas E.
    Shimabukuro, Tom
    Sturkenboom, Miriam
    van Dinthers, Kristy
    Wiznitzer, Max
    Bonhoeffer, Jan
    VACCINE, 2013, 31 (06) : 994 - 1007
  • [17] Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation
    Marcy, SM
    Kohl, KS
    Dagan, R
    Nalin, D
    Blum, M
    Jones, MC
    Hansen, J
    Labadie, J
    Lee, L
    Martin, BL
    O'Brien, K
    Rothstein, E
    Vermeer, P
    VACCINE, 2004, 22 (5-6) : 551 - 556
  • [18] Case Study of Adverse Event Following Immunization of Diphtheria, Pertussis (Whooping Cough), and Tetanus Vaccine-Induced Encephalopathy in an Infant
    Parimalakrishnan, S.
    Madheswaran, M.
    Baby, Eldho
    Balu, R.
    Smith, A. Anton
    ASIAN JOURNAL OF PHARMACEUTICS, 2016, 10 (02) : S189 - S191
  • [19] Case Study: How Analysis of Customer Found Defects Can Be Used by System Test to Improve Quality
    Moritz, Evelyn
    2009 31ST INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING, COMPANION VOLUME, 2009, : 123 - 129
  • [20] Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation
    Rothstein, E
    Kohl, KS
    Ball, L
    Halperin, SA
    Halsey, N
    Hammer, SJ
    Heath, PT
    Hennig, R
    Kleppinger, C
    Labadie, J
    Varricchio, F
    Vermeer, P
    Walop, W
    VACCINE, 2004, 22 (5-6) : 575 - 585